Banerjee Tapas Kumar, Das Shyamal Kumar
Head of Department of Neurology, National Neuroscience Centre, Kolkata, West Bengal, India.
Department of Neurology, Burdwan Medical College, Burdwan, West Bengal, India.
Ann Indian Acad Neurol. 2016 Jan-Mar;19(1):1-8. doi: 10.4103/0972-2327.168631.
Currently, the stroke incidence in India is much higher than Western industrialized countries. Large vessel intracranial atherosclerosis is the commonest cause of ischemic stroke in India. The common risk factors, that is, hypertension, diabetes, smoking, and dyslipidemia are quite prevalent and inadequately controlled; mainly because of poor public awareness and inadequate infrastructure. Only a small number of ischemic stroke cases are able to have the benefit of thrombolytic therapy. Benefits from stem cell therapy in established stroke cases are under evaluation. Presently, prevention of stroke is the best option considering the Indian scenario through control and/or avoiding risk factors of stroke. Interventional studies are an important need for this scenario.
目前,印度的中风发病率远高于西方工业化国家。颅内大血管动脉粥样硬化是印度缺血性中风最常见的病因。常见的危险因素,即高血压、糖尿病、吸烟和血脂异常非常普遍且控制不佳;主要原因是公众意识淡薄和基础设施不足。只有少数缺血性中风病例能够受益于溶栓治疗。干细胞疗法对已确诊中风病例的疗效正在评估中。目前,考虑到印度的情况,通过控制和/或避免中风危险因素来预防中风是最佳选择。针对这种情况,介入性研究非常必要。